FDA inspection
SPI Pharma, Inc.: FDA inspection ending Apr 29, 2019
FDA inspection 1090151 · No Action Indicated (NAI) · Grand Haven, MI
Key facts
| Inspection ID | 1090151 |
|---|---|
| Firm | SPI Pharma, Inc. |
| FEI number | 1833292 |
| Address | 1711 Tiles Ct |
| City | Grand Haven |
| State | MI |
| ZIP | 49417 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 29, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data